Emily Lobelo helps clients develop and implement federal, state, and global policy strategies leveraging the latest analytics, trends, and opportunities, focusing particularly on vaccine business insights and strategy.

Before joining Avalere, Emily worked at the Centers for Disease Control and Prevention (CDC) for nearly 15 years. While at the CDC, Emily served in several policy leadership roles, including as the long-time director for influenza policy, as a senior leader for preparedness and response policy, and as the policy lead for several public health responses, including the COVID-19 response.

Emily holds a bachelor’s degree in political science and a master’s degree in journalism from Northwestern University. She also holds a doctorate in health policy and management from the Tulane University School of Public Health and Tropical Medicine, where she analyzed the cost-effectiveness of influenza vaccination based on household income and researched influenza vaccination coverage among US adults.

Authored Content

WHO and VRBPAC recommendations to move back toward trivalent influenza vaccines may cause significant shifts in the global flu vaccine landscape.

The IRA expanded vaccine access, but variations in federal policies governing vaccine coverage requirements and implementation remain

In light of the growing therapeutic vaccine pipeline, policymakers are starting to define coverage, access, and reimbursement pathways.